福安药业：头孢托仑匹酯颗粒获药品注册证书

Core Viewpoint - Fuan Pharmaceutical's subsidiary, Qingyutang, has received a drug registration certificate from the National Medical Products Administration for its product, Cefotolan Pivoxil Granules, indicating a significant regulatory milestone for the company [1] Group 1: Product Information - Cefotolan Pivoxil Granules are indicated for a variety of infections caused by sensitive bacteria, including superficial and deep skin infections, lymphangitis, chronic pyoderma, and secondary infections from trauma, burns, and surgical wounds [1] - The drug is also applicable for treating perianal abscesses, pharyngitis, laryngitis, tonsillitis, acute bronchitis, pneumonia, lung abscesses, chronic respiratory system diseases, otitis media, sinusitis, periodontitis, jaw inflammation, cystitis, pyelonephritis, scarlet fever, and whooping cough [1]